Chris Yates

Chris Yates is an experienced executive in the field of medicinal chemistry, currently serving as the Executive Director and Head of Medicinal Chemistry at Rgenta Therapeutics Inc. since August 2022. Prior roles include Senior Director of Medicinal Chemistry at Kymera Therapeutics, Director and Associate Director of Chemistry at Kymera Therapeutics, Director of Medicinal Chemistry at Selenity Therapeutics, and Director of Medicinal Chemistry at Viamet Pharmaceuticals, where tenure spanned from May 2010 to August 2018. Chris Yates began a career in research as a Scientist at GlaxoSmithKline from May 2004 to May 2010. Academic credentials include a Master's degree in Organic Chemistry from the University of North Carolina at Chapel Hill and a Bachelor's degree with Honors in Chemistry from Wake Forest University.